Japan
Review Article
Surgical Treatment for Esophageal Cancer
Author(s): Masayuki Watanabe, Yoshifumi Baba, Naoya Yoshida and Hideo BabaMasayuki Watanabe, Yoshifumi Baba, Naoya Yoshida and Hideo Baba
Esophagectomy is the main treatment for esophageal cancer. The 2 histologic subtypes of esophageal cancer are squamous cell carcinoma and adenocarcinoma; these subtypes have different biologic features and treatment strategies. Although the prognosis of patients treated with surgery alone remains unsatisfactory, neoadjuvant therapy helps to improve outcome. A meta-analysis revealed that neoadjuvant chemoradiotherapy provides survival benefits for both histologic types, while neoadjuvant chemotherapy is useful for adenocarcinoma. In Western countries, neoadjuvant chemoradiotherapy is a standard treatment for resectable advanced esophageal cancer, while neoadjuvant chemotherapy has become the standard treatment in Japan. Esophagectomy can be performed by several different approaches, including McKeown (cervico-thoraco-abdominal), Ivor-Lewis (thoraco-abdominal), and tran.. Read More»
DOI:
10.4172/2155-9619.S2-004
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report